M. BEKSAÇ Et Al. , "In vitro binding and complement dependent cytotoxicity (CDC) of Rituximab(R) in patients with chronic B-lymphoproliferative disorders: Effects of glycosylphosphatidil inositol (GIP) expression and cyclosporin A (CsA).," 45th Annual Meeting of the American-Society-of-Hematology , vol.102, SAN DIEGO, CALIFORNIA, 2003
BEKSAÇ, M. Et Al. 2003. In vitro binding and complement dependent cytotoxicity (CDC) of Rituximab(R) in patients with chronic B-lymphoproliferative disorders: Effects of glycosylphosphatidil inositol (GIP) expression and cyclosporin A (CsA).. 45th Annual Meeting of the American-Society-of-Hematology , (SAN DIEGO, CALIFORNIA).
BEKSAÇ, M., Dalva, K., & Akar, G., (2003). In vitro binding and complement dependent cytotoxicity (CDC) of Rituximab(R) in patients with chronic B-lymphoproliferative disorders: Effects of glycosylphosphatidil inositol (GIP) expression and cyclosporin A (CsA). . 45th Annual Meeting of the American-Society-of-Hematology, SAN DIEGO, CALIFORNIA
BEKSAÇ, MERAL, KLARA DALVA, And G Akar. "In vitro binding and complement dependent cytotoxicity (CDC) of Rituximab(R) in patients with chronic B-lymphoproliferative disorders: Effects of glycosylphosphatidil inositol (GIP) expression and cyclosporin A (CsA).," 45th Annual Meeting of the American-Society-of-Hematology, SAN DIEGO, CALIFORNIA, 2003
BEKSAÇ, MERAL Et Al. "In vitro binding and complement dependent cytotoxicity (CDC) of Rituximab(R) in patients with chronic B-lymphoproliferative disorders: Effects of glycosylphosphatidil inositol (GIP) expression and cyclosporin A (CsA).." 45th Annual Meeting of the American-Society-of-Hematology , SAN DIEGO, CALIFORNIA, 2003
BEKSAÇ, M. Dalva, K. And Akar, G. (2003) . "In vitro binding and complement dependent cytotoxicity (CDC) of Rituximab(R) in patients with chronic B-lymphoproliferative disorders: Effects of glycosylphosphatidil inositol (GIP) expression and cyclosporin A (CsA).." 45th Annual Meeting of the American-Society-of-Hematology , SAN DIEGO, CALIFORNIA.
@conferencepaper{conferencepaper, author={MERAL BEKSAÇ Et Al. }, title={In vitro binding and complement dependent cytotoxicity (CDC) of Rituximab(R) in patients with chronic B-lymphoproliferative disorders: Effects of glycosylphosphatidil inositol (GIP) expression and cyclosporin A (CsA).}, congress name={45th Annual Meeting of the American-Society-of-Hematology}, city={SAN DIEGO}, country={CALIFORNIA}, year={2003}}